Mycoplasma genitalium

Monitoring of macrolide resistanceassociated mutations in Mycoplasma genitalium in Russia

Objective. To determine spectrum and prevalence of genetic determinants of resistance to macrolides in Mycoplasma genitalium in a Russian patient population. Materials and Methods. A total of 873 M. genitalium-positive samples from five geographical regions of Russia were investigated over the period of 2009–2019 using the previously developed protocol of real-time polymerase chain reaction (allows detecting any nucleotide substitutions in the 23S rRNA gene of M. genitalium at positions 2058, 2059, and 2611).

The rates of mutations associated with macrolide resistance in Mycoplasma genitalium among patients with non-gonococcal sexually transmitted infections in Smolensk and Tula

Objective. In this study, we examined the prevalence of macrolide-resistant M. genitalium in two Russian cities, Smolensk and Tula, between 2013 and 2017. Materials and Methods. DNA’s samples were isolated from urethral and cervicovaginal swabs using primary screening and tested for macrolide resistance-associated mutations by real-time PCR. This technology makes it possible to identify any nucleotide substitutions in the 23S rRNA M. genitalium gene at positions 2058, 2059, 2611 M.

The Role of Ureaplasma urealyticum and Mycoplasma genitalium in Etiology of Urogenital Infections

The role of Mycoplasma hominis, Ureaplasma urealyticum and Mycoplasma genitalium in the etiology of urogenital infections has been studied. In the study group (n=92) patients with gonococcal and chlamydial infections as well as with bacterial …